Bernard D. Goldstein, MD: An Overview of Risk Assessment
Bernard D. Goldstein, MD: An Overview of Risk Assessment
Bernard D. Goldstein, MD
University of Pittsburgh
Graduate School of Public Health
Scientists manipulate
formulae to match the
real world.
Policymakers manipulate
the real world to match
formulae.
Research and
Data Collection
Risk
Assessment
Risk
Management
Hazard Identification
The determination of whether a
particular chemical or agent is or is
not causally linked to a particular
health effect.
Carcinogenic to Humans
2A
Probably Carcinogenic
2B
Possibly Carcinogenic
Not Classifiable
Weight of Evidence
Dose-Response Curve
Observable
Range
Response
Range of
Inference
Dose
Structure of DNA
Transport and
Transformation
Health Effect
Accumulation
in
Environment
Early
Expression of
Disease
Human
Contact
Exposure
Biologically
Effective Dose
Elimination
Accumulation
Transformation
Potential Dose
to the Body
Internal Dose
Bioavailability
Risk Characterization
The description of the nature and
often the magnitude of the human
risk, including attendant
uncertainty.
Risk Assessment
Dose-Response
Assessment
Hazard
Identification
Risk
Characterization
Exposure
Assessment
Risk Assessment
Risk Management
DoseResponse
Assessment
Hazard
Identification
Exposure
Assessment
Risk
Characterization
Regulatory
Decision
Control
Options
Non-Risk
Analysis
X XX XX X
X X
X X
Communication
of Science
CONSENSUS by SCIENTISTS
BALANCE by JOURNALISTS
CONFRONTATION by LAWYERS
CATNIP PRINCIPLE
Cheapest Available Technology
Not Involving Prosecution
Margin of Safety
Is it Risk Assessment or Risk Management?
Components of decision:
What is strength of positive data?
What is strength of negative data?
Is uncertainty qualitative or quantitative?
What is the clinical significance of risk?
continued)
Provide consistency
Establish data quality objectives
Assure technical quality
Clarify scientific assumptions
Allow flexibility to be transparent
Provide public with Road Map
Framework is Conducted:
In collaboration with stakeholders.
Using iterations if new information
is developed that changes the need
for or nature of risk management.